Artificial Iris Market: Current Scenario and Forecast (2019-2025)

Abstract
Aging is a natural process concerning physiological, cellular, psychological, social changes of an organism over a period. It is not just restricted to a single region rather affecting the whole world. By 2050, the world's population aged 60 years and older is expected to reach 2 billion, up from 900 million in 2015. Currently, 125 million people are aged 80 years or above. Countries like India where the population pyramid was of expanding type will soon show a change due to the aging and increased life expectancy. It leads to the onset of several eye defects. Some of the eye defects are hereditary such as aniridia. It is a congenital, hereditary, bilateral, extreme form of iris hypoplasia that may be associated with other ocular defects. It describes an extreme form of iris hypoplasia in which the iris appears absent on superficial clinical examination. However, gonioscopy shows the presence of the iris root. Aniridia is not just an isolated defect in iris development but is a panocular disorder with macular and optic nerve hypoplasia, cataract, and corneal changes that are other anomalies that lead to decreased vision and nystagmus. Other conditions that lead to the disruption of iris include Iris hypoplasia, Congenital mydriasis and Iris coloboma. advent of artificial iris lead to the therapeutic treatment of this condition. Artificial iris derived a revenue of US$ 10.61 Million in 2018 and is expected to fetch US$ 16.28 Million by 2025 displaying tremendous CAGR of 6.39% over the forecast period (2019-2025).

The global artificial iris market is segmented based on material type (Fiber and Fiber Free), Age group (Pediatric and Adult Cohorts), colour (blue, brown and other colour), application (cosmetic and therapeutic) and end-users (hospitals, eye surgery centers and other end user) are the major focus areas considered while analyzing and defining the penetration of artificial iris at global scale. Under the material type segment, in 2018, the fibre-free dominated the global artificial iris market with the maximum share in terms of revenue. Based on estimation, the segment occupied 55.3% share in 2018. Adult Cohorts dominated the age group segment. Amongst the colour segment blue colour dominated the market with a revenue of US$ 4.75 million in 2018, followed by brown. Therapeutics is the application of the artificial iris and is utilized by the patients suffering from major iris defects. Hospital is the major institution where patients undergo this procedure of artificial iris implantation. Also, for better understanding of the overall adoption rate of artificial iris in different market, detailed analysis has been done for different regions/countries including North America (US, Rest of the North America), Europe (Germany, Netherlands and Rest of the Europe), Asia Pacific (China, India, Japan and Rest of the APAC), and the rest of the world (Middle East and Latin America). Based on the estimation, Europe dominated the global artificial iris market, accounting for revenue share of 41.2% in 2018. On account of the strong presence of major market players.

Numerous companies have earmarked their presence in the global artificial iris market with continued focus on product expansions, investments, business expansion, product launches and collaborations. Some of the major players operating in the global artificial iris market include Ophtec, HumanOptics AG, Morcher, ReperNN, VEO Ophthalmics, Spectrum Surgical, Eye-yon Medical and Pixium vision.

Global artificial iris market generated revenue of US$ 10.61 million in 2018. The technology is expected to grow at a CAGR of 6.39% during the forecast period to reach a market valuation of US$ 16.28 million by 2025. Europe dominated the global artificial iris, accounting for revenue share of 41.2% in 2018.

Content
1. MARKET INTRODUCTION
1.1Market Definition16
1.2Objective of the Study16
1.3Limitation16
1.4Stakeholders16
1.5Currency used in the Report17
1.6Scope of the Global Artificial Iris Market Study17
2.RESEARCH METHODOLOGY OR ASSUMPTION18
2.1Research Methodology for Global Artificial Iris Market Study18
2.1.1Main objective of the Artificial Iris Market Study19
3.INDUSTRY PERFORMANCE20
4.EXECUTIVE SUMMARY22
5.CURRENT AND PROJECTED SCENARIO OF THE WORLD'S EYESIGHT24
5.1General Overview24
5.1.1Key Facts on the state of the world's eyesight24
5.1.2Improving the world’s Eyesight; the Goals of Vision 202028
6.MARKET OVERVIEW30
6.1Introduction30
6.2Market Dynamics31
6.2.1Market Drivers31
6.2.1.1Accelerating Geriatric Population31
6.2.1.1.1Some of the Key Facts regarding Ageing and health31
6.2.1.2Growing Number of Eye Defects33
6.2.1.3Increasing Demand of Minimally Invasive Surgical Procedures34
6.2.1.4Rising Healthcare Expenditure and Health-Conscious Personals34
6.2.2Market Restraints38
6.2.2.1Side Effects Associated with Implant Procedure38
6.2.2.2Lack of Reimbursement38
6.2.2.3Lack of Trained Professionals39
6.2.3Market Opportunities39
6.2.3.1Artificial Intelligence (AI) in Ophthalmology39
7.TECHNIQUES FOR ARTIFICIAL IRIS IMPLANTATION41
7.1Overview41
7.1.1Surgical Techniques41
7.1.2Techniques42
7.1.3Sector- or Segment-Shaped Artificial Iris Sutured Side-by-Side to the Residual Iris43
7.1.4Injector-Assisted Sulcus-Fixated Complete Iris in Pseudophakic Eyes43
7.1.5Injector-Assisted Implantation of a Complete Iris in the Capsular Bag in Combination with Planned Standard Cataract Surgery43
7.1.6Complete Iris Prosthesis Implantation Sutured to the Sclera in Combination with a Scleral-Fixated Intraocular Lens in Aniridia and Aphakia of Vitrectomized Eyes44
7.1.7“Sandwich” or “Backpack” Iris Prosthesis Implantation in Combination with an Intraocular Lens in Aniridia and Aphakia44
7.1.8Open-Sky Implantation During a Perforating Keratoplasty45
8.DEMAND AND SUPPLY SIDE ANALYSIS46
8.1Demand Side Analysis46
8.2Supply Side Analysis47
8.2.1Top Product Launch48
8.2.2Top Partnerships48
8.2.3Top Business Expansion & Investment48
8.2.4Value Chain Analysis of Artificial Iris49
9.PIPELINE ACTIVITY50
9.1EndoArt Artificial Endothelial Layer: Eye-yon Medical50
9.1.1Product Description50
9.1.2Research and Development50
9.2Retinal Implant System (IRIS): Intelligent Medical Implants51
9.2.1Product Description51
9.2.2Research and Development51
10.MARKET INSIGHTS BY MATERIAL TYPE52
10.1General Overview52
10.1.1Fiber Artificial Iris54
10.1.1.1Case Study: Comparison of complication rate for artificial iris with or without mesh55
10.1.2Fiber-free Artificial Iris56
11.MARKET INSIGHTS BY COLOUR58
11.1General Overview58
11.1.1Blue Colour Artificial Iris60
11.1.2Brown Colour Artificial Iris61
11.1.3Other Colour Artificial Iris61
12.MARKET INSIGHTS BY APPLICATION63
12.1General Overview63
12.1.1Cosmetic Application64
12.1.2Therapeutic Application65
13.MARKET INSIGHTS BY AGE GROUP67
13.1General Overview67
13.1.1Pediatric68
13.1.2Adults71
14.MARKET INSIGHTS BY END-USERS73
14.1General Overview73
14.1.1Hospitals74
14.1.2Eye Surgery Centers75
14.1.3Others Eye Care Facility77
15.MARKET INSIGHTS BY REGION78
15.1General Overview78
15.2North America Artificial Iris Market (2018-2025)80
15.2.1North America Artificial Iris Market by Material Type80
15.2.2North America Artificial Iris Market by Colour81
15.2.3North America Artificial Iris Market by Application81
15.2.4North America Artificial Iris Market by Age Group82
15.2.5North America Artificial Iris Market by End-User82
15.2.6North America Artificial Iris Market by Country83
15.2.6.1United States Artificial Iris Market (2018-2025)83
15.2.6.1.1Eye Health Statistics, US84
15.2.6.1.2US Health Spending by Type of Service or Product, 201785
15.2.6.1.3Health Spending by Major Sources of Funds87
15.2.6.1.4US Artificial Iris Market by Material Type88
15.2.6.1.5US Artificial Iris Market by Colour88
15.2.6.1.6US Artificial Iris Market by Application89
15.2.6.1.7US Artificial Iris Market by Age Group89
15.2.6.1.8US Artificial Iris Market by End-User90
15.2.6.2Canada Artificial Iris Market (2018-2025)90
15.2.6.2.1The Prevalence of Canadian Vision Loss and Cataract Surgery90
15.2.6.2.2Key Findings on Canada Healthcare Spending, 201892
15.2.6.2.3Key Findings on Hospital sector Spending in Canada, 201793
15.2.6.2.4Canadian Population Projection94
15.2.6.2.5Canada Artificial Iris Market by Material Type94
15.2.6.2.6Canada Artificial Iris Market by Colour95
15.2.6.2.7Canada Artificial Iris Market by Application95
15.2.6.2.8Canada Artificial Iris Market by Age Group96
15.2.6.2.9Canada Artificial Iris Market by End-User96
15.2.6.3Rest of North America Artificial Iris market (2018-2025)97
15.2.6.3.1Rest of North America Artificial Iris Market by Material Type98
15.2.6.3.2Rest of North America Artificial Iris Market by Colour99
15.2.6.3.3Rest of North America Artificial Iris Market by Application99
15.2.6.3.4Rest of North America Artificial Iris Market by Age Group100
15.2.6.3.5Rest of North America Artificial Iris Market by End-User100
15.3Europe Artificial Iris Market (2018-2025)101
15.3.1Europe Artificial Iris Market by Material Type101
15.3.2Europe Artificial Iris Market by Colour102
15.3.3Europe Artificial Iris Market by Application102
15.3.4Europe Artificial Iris Market by Age Group103
15.3.5Europe Artificial Iris Market by End-User103
15.3.6Europe Artificial Iris Market by Country104
15.3.6.1Germany Artificial Iris Market (2018-2025)104
15.3.6.1.1Germany Artificial Iris Market by Material Type105
15.3.6.1.2Germany Artificial Iris Market by Colour106
15.3.6.1.3Germany Artificial Iris Market by Application106
15.3.6.1.4Germany Artificial Iris Market by Age Group107
15.3.6.1.5Germany Artificial Iris Market by End-User107
15.3.6.2Netherlands Artificial Iris Market (2018-2025)108
15.3.6.2.1Netherlands Artificial Iris Market by Material Type108
15.3.6.2.2Netherlands Artificial Iris Market by Colour109
15.3.6.2.3Netherlands Artificial Iris Market by Application109
15.3.6.2.4Netherlands Artificial Iris Market by Age Group110
15.3.6.2.5Netherlands Artificial Iris Market by End-User110
15.3.6.3Rest of Europe Artificial Iris Market (2018-2025)111
15.3.6.3.1Rest of Europe Artificial Iris Market by Material Type111
15.3.6.3.2Rest of Europe Artificial Iris Market by Colour111
15.3.6.3.3Rest of Europe Artificial Iris Market by Application112
15.3.6.3.4Rest of Europe Artificial Iris Market by Age Group112
15.3.6.3.5Rest of Europe Artificial Iris Market by End-User113
15.4Asia Pacific Artificial Iris Market (2018-2025)113
15.4.1Asia-Pacific Artificial Iris Market by Material Type115
15.4.2Asia-Pacific Artificial Iris Market by Colour115
15.4.3Asia-Pacific Artificial Iris Market by Application116
15.4.4Asia-Pacific Artificial Iris Market by Age Group116
15.4.5Asia-Pacific Artificial Iris Market by End-User117
15.4.6Asia Pacific Artificial Iris Market by Country117
15.4.6.1Japan Artificial Iris Market (2018-2025)118
15.4.6.1.1Japan Artificial Iris Market by Material Type119
15.4.6.1.2Japan Artificial Iris Market by Colour119
15.4.6.1.3Japan Artificial Iris Market by Application120
15.4.6.1.4Japan Artificial Iris Market by Age Group120
15.4.6.1.5Japan Artificial Iris Market by End-User121
15.4.6.2China Artificial Iris Market (2018-2025)121
15.4.6.2.1China Artificial Iris Market by Material Type122
15.4.6.2.2China Artificial Iris Market by Colour123
15.4.6.2.3China Artificial Iris Market by Application123
15.4.6.2.4China Artificial Iris Market by Age Group124
15.4.6.2.5U China S Artificial Iris Market by End-User124
15.4.6.3India Artificial Iris Market (2018-2025)125
15.4.6.3.1India Artificial Iris Market by Material Type125
15.4.6.3.2India Artificial Iris Market by Colour126
15.4.6.3.3India Artificial Iris Market by Application126
15.4.6.3.4India Artificial Iris Market by Age Group127
15.4.6.3.5India Artificial Iris Market by End-User127
15.4.6.4Rest of APAC Artificial Iris Market (2018-2025)128
15.4.6.4.1Rest of APAC Artificial Iris Market by Material Type129
15.4.6.4.2Rest of APAC Artificial Iris Market by Colour130
15.4.6.4.3Rest of APAC Artificial Iris Market by Application130
15.4.6.4.4Rest of APAC Artificial Iris Market by Age Group131
15.4.6.4.5Rest of APAC Artificial Iris Market by End-User131
15.5Rest of World Artificial Iris Market (2018-2025)132
15.5.1ROW Artificial Iris Market by Material Type133
15.5.2ROW Artificial Iris Market by Colour134
15.5.3ROW Artificial Iris Market by Application134
15.5.4ROW Artificial Iris Market by Age Group135
15.5.5ROW Artificial Iris Market by End-User135
16.COMPETITIVE SCENARIO136
16.1Porter’s Five forces analysis136
16.1.1Bargaining power of Supplier137
16.1.2Bargaining power of Buyer137
16.1.3Industry Rivalry137
16.1.4Availability of Substitute137
16.1.5Threat of new Entrants138
17.TOP COMPANY PROFILES139
17.1Morcher139
17.1.1Key Facts139
17.1.2Business Description139
17.1.3Key Product/Services Offerings139
17.1.4Growth Strategy142
17.2Ophtec144
17.2.1Key Facts144
17.2.2Business Description144
17.2.3Key Product/Services Offerings145
17.2.4Growth Strategy147
17.2.5SWOT Analysis147
17.2.6Recent Developments148
17.2.6.1Partnerships (Strategic Alliance)148
17.2.6.2Business Expansion148
17.3HumanOptics149
17.3.1Key Facts149
17.3.2Business Description149
17.3.3Key Product/Services Offerings149
17.3.4Growth Strategy150
17.3.5SWOT Analysis150
17.4Reper NN151
17.4.1Key Facts151
17.4.2Business Description151
17.4.3Key Product/Services Offerings151
17.5VEO Ophthalmics152
17.5.1Key Facts152
17.5.2Business Description152
17.5.3Key Product/Services Offerings152
17.5.4Recent Developments153
17.5.4.1Product Launches153
17.5.4.2Partnership153
17.6Spectrum Surgical154
17.6.1Key Facts154
17.6.2Business Description154
17.6.3Key Product/Services Offerings155
17.6.4Growth Strategy156
17.7EyeYon Medical157
17.7.1Key Facts157
17.7.2Business Description157
17.7.3Key Product/Services Offerings157
17.7.4Growth Strategy157
17.8Pixium Vision159
17.8.1Key Facts159
17.8.2Business Description160
17.8.3Key Product/Services Offerings160
17.8.4Growth Strategy160
17.8.5SWOT Analysis162
17.8.6Key Financials163
17.8.7Recent Developments164
17.8.7.1Product Launches164